LEPRA: DESCRIPTION OF A FRESH CASE IN UKRAINE
About the author:	T.V. Sviatenko, A.V. Kalmykova, Yu.V. Rybak	
Heading	CLINICAL CASES	
Type of article	Scientific Article	
Annotation	The objective: to acquaint dermatovenerologists of Ukraine with a fresh case of leprosy and recall the clinical features of the disease. The object of the study was the modern features of the course of leprosy, the difficulties of diagnosis and differential diagnosis of the disease. Materials and methods. We observed a 78-year-old man who was treated for a long time with a diagnosis of sarcoidosis in the community. It was possible to establish a diagnosis using histological and bacterioscopic research methods. Results and conclusions. Given the fact that leprosy refers to social diseases, the registration of fresh cases, an increase in the incidence by analogy with other chronic infectious diseases that seemed already defeated (tuberculosis, syphilis, malaria) may be due to worsening socio-economic and environmental living conditions, as well as tourist and migration processes from regions affected
by leprosy. Therefore, in our opinion, doctors, may find the case of observation described by us interesting and useful in further practice.	
Tags	leprosy, treatment, diagnosis, differential diagnosis	
Bibliography	1. Kubanov A A, Karamova A E, Voroncova A A, Kalinina P A. Farmakoterapiya lepry (Pharmacotherapy of leprosy). Vestn. derm. ven. 2016;4:12–19.
2.  Global  Leprosy  Strategy  2016–2020:  Accelerating  towards  a  leprosy-free  world.  WHO Regional Office for South-East Asia. 2016.
3. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. New Delhi: World Health Organization, Regional Office for South-East Asia; 2018.
4. Lockwood D NJ, Krishnamurthy P. Single-dose rifampicin chemoprophylaxis protects those who need it least and is not a cost-effective intervention. PLoS Negl Trop Dis. 2018;12(6).
5. Prasad P V, Babu A, Kaviarasan P K. MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment. Indian J Dermatol Venereol Leprol. 2005;71(4):242–5.
6. Penna G O, Buhrer-Sekula S, Kerr LRS, et al. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. PLoS Negl Trop Dis. 2017;11(7).
7.  World  Health  Organization.  Global  Leprosy  Programme.  Global  leprosy  strategy  2016–2020. Accelerating towards a leprosy-free world. 2016. http://apps.who.int/iris/bitstream/handl e/10665/208824/9789290225096_en.pdf?sequence=14&isAllowed=y  [Accessed  17  October 2018]	
Publication of the article	«DERMATOLOGY AND VENEREOLOGY» №3(89), 2020 year, 39-43 pages,
 index UDK 616.53–002–036–08–055	
DOI	10.33743/2308-1066-2020-3-39-43